Swiss stocks are experiencing a lack of direction, with Lonza, Richemont, Swiss Re, and Nestlé seeing increased demand. In Japan, share prices are pressured by the appointment of an anti-vaccination campaigner to a key health position, significantly impacting pharmaceutical stocks, particularly Chugai Pharmaceutical, which dropped 8.56%. Equity strategist Kazuo Kamitani suggests ongoing market turbulence, exacerbated by a strong yen affecting export-oriented carmakers.
